Dexcom has been hit by a major safety issue for an Android version of its G6 continuous monitoring system app, leading the FDA to issue its most serious recall notice. | Dexcom has been hit by a major ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to download ...

DexCom (DXCM) stock ought to be included on your watchlist. Here is why – it is presently trading within the support range ($55.31 – $61.13), levels from ...

With the new funds, the company’s valuation is nearly $1 billion, a Synchron spokesperson said. That makes it the second-most ...

Q3 2025 Earnings Call Transcript October 30, 2025 DexCom, Inc. beats earnings expectations. Reported EPS is $0.61, ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) fell 6% in the afternoon session after investor ...

Senseonics Holdings Inc (SENS) reports impressive revenue growth and strategic advancements, despite facing challenges in ...

Analysts anticipate Insulet to report an earnings per share (EPS) of $1.14. The market awaits Insulet's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for ...

The company reported that 160% growth in new patient shipments over the prior-year period fueled the 90% year-over-year revenue growth. Direct-to-consumer (DTC) investments drove a 300% increase in ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service ...

The medtech ecosystem is ever-evolving worldwide, and Ireland is one of the more interesting pieces of the puzzle.

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...